Multiple endocrine neoplasia type 1 MRI: Difference between revisions
Jump to navigation
Jump to search
Line 14: | Line 14: | ||
===Somatostatinoma<ref name=Radiopaedia072015>{{cite web | title = Radiopedia2015 Somatostatinoma [Dr Yuranga Weerakkody]| url = http://radiopaedia.org/articles/somatostatinoma }}</ref>=== | ===Somatostatinoma<ref name=Radiopaedia072015>{{cite web | title = Radiopedia2015 Somatostatinoma [Dr Yuranga Weerakkody]| url = http://radiopaedia.org/articles/somatostatinoma }}</ref>=== | ||
* Smaller lesions may be difficult to diagnose. | * Smaller lesions may be difficult to diagnose. | ||
:* T1: low signal 1,8 | * Signal characteristics of larger lesion include: | ||
:* T2: high signal 1,8 | :* '''T1''': low signal 1,8 | ||
:* T1 (C+) Gd: most show early diffuse heterogenous enhancement | :* '''T2''': high signal 1,8 | ||
:* '''T1 (C+) Gd''': most show early diffuse heterogenous enhancement | |||
==Reference== | ==Reference== | ||
{{Reflist}} | {{Reflist}} | ||
[[Category:Hereditary cancers]] | [[Category:Hereditary cancers]] |
Revision as of 11:33, 11 September 2015
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 MRI On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 MRI |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
MRI may be helpful in the diagnosis of multiple endocrine neoplasia type 1.
MRI
Gastrointestinal Neuroendocrine Tumors[1]
- MRI isw used for suspected hepatic, pancreatic or retroperitoneal neuroendocrine tumors, often with gadolinium contrast.
- MRI enterography is also possible.
Insulinoma[2]
- Dynamic MRI with fast gradient echo sequences following bolus injection of contrast medium may aid the detection of these tumors[3]
- T1 C+ (Gd): typically shows enhancement, although contrast enhancement may not improve tumour visualisation compared with non-contrast images
Somatostatinoma[4]
- Smaller lesions may be difficult to diagnose.
- Signal characteristics of larger lesion include:
- T1: low signal 1,8
- T2: high signal 1,8
- T1 (C+) Gd: most show early diffuse heterogenous enhancement
Reference
- ↑ "Radiopedia2015 Gastrointestinal neuroendocrine tumours [Dr Dalia Ibrahim and Dr Jan Smith]".
- ↑ "Radiopedia2015 Insulinoma [Dr Yuranga Weerakkody and Dr Frank Gaillard]".
- ↑ Owen NJ, Sohaib SA, Peppercorn PD, Monson JP, Grossman AB, Besser GM; et al. (2001). "MRI of pancreatic neuroendocrine tumours". Br J Radiol. 74 (886): 968–73. doi:10.1259/bjr.74.886.740968. PMID 11675319.
- ↑ "Radiopedia2015 Somatostatinoma [Dr Yuranga Weerakkody]".